Windlas Biotech Share Price
Start SIP in Windlas Biotech
Start SIPWindlas Biotech Performance
Day Range
- Low 870
- High 899
52 Week Range
- Low 312
- High 952
- Open Price879
- Previous Close887
- Volume27569
Windlas Biotech Investment Rating
-
Master Rating:
-
Windlas Biotech has an operating revenue of Rs. 661.32 Cr. on a trailing 12-month basis. An annual revenue growth of 23% is outstanding, Pre-tax margin of 12% is healthy, ROE of 12% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 10% and 47% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 11% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 74 which is a FAIR score but needs to improve its earnings, a RS Rating of 85 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 13 indicates it belongs to a strong industry group of Medical-Ethical Drugs and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 175 | 171 | 162 | 153 | 145 | 141 |
| Operating Expenses Qtr Cr | 154 | 149 | 142 | 134 | 128 | 124 |
| Operating Profit Qtr Cr | 21 | 22 | 20 | 19 | 17 | 16 |
| Depreciation Qtr Cr | 6 | 4 | 3 | 3 | 3 | 4 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 5 | 6 | 5 | 4 | 4 | 4 |
| Net Profit Qtr Cr | 13 | 17 | 15 | 14 | 12 | 11 |
Windlas Biotech Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 13
- Bearish Moving Average
- ___
- 3
- 20 Day
- ₹868.97
- 50 Day
- ₹813.47
- 100 Day
- ₹738.31
- 200 Day
- ₹634.89
- 20 Day
- ₹864.01
- 50 Day
- ₹806.37
- 100 Day
- ₹717.04
- 200 Day
- ₹605.32
Windlas Biotech Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 906.40 |
| Second Resistance | 917.50 |
| Third Resistance | 935.70 |
| RSI | 59.20 |
| MFI | 59.63 |
| MACD Single Line | 27.83 |
| MACD | 27.44 |
| Support | |
|---|---|
| First Support | 877.10 |
| Second Support | 858.90 |
| Third Supoort | 847.80 |
Windlas Biotech Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 29,286 | 1,548,644 | 52.88 |
| Week | 55,516 | 2,442,704 | 44 |
| 1 Month | 63,918 | 2,950,434 | 46.16 |
| 6 Month | 84,980 | 4,068,826 | 47.88 |
Windlas Biotech Result Highlights
Windlas Biotech Synopsis
NSE-Medical-Ethical Drugs
Windlas Biotech is involved in the business activities of Manufacture of pulp, paper and paperboard. Company’s Total Operating Revenue is Rs. 630.96 Cr. and Equity Capital is Rs. 10.40 Cr. for the Year ended 31/03/2024. Windlas Biotech Ltd. is a Public Limited Listed company incorporated on 19/02/2001 and has its registered office in the State of Uttarakhand/Uttaranchal, India. Company’s Corporate Identification Number(CIN) is L74899UR2001PLC033407 and registration number is 033407.| Market Cap | 1,854 |
| Sales | 661 |
| Shares in Float | 0.77 |
| No of funds | 22 |
| Yield | 0.62 |
| Book Value | 4.1 |
| U/D Vol ratio | 1.6 |
| LTDebt / Equity | |
| Alpha | 0.28 |
| Beta | 1.08 |
Windlas Biotech Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 62.51% | 62.82% | 62.82% | 62.82% |
| Mutual Funds | 8.7% | 10.37% | 10.4% | 10.43% |
| Foreign Portfolio Investors | 1.59% | 1.18% | 1.35% | 0.8% |
| Financial Institutions/ Banks | 0.04% | 0.04% | ||
| Individual Investors | 21.76% | 21.19% | 21.21% | 21.63% |
| Others | 5.44% | 4.44% | 4.18% | 4.28% |
Windlas Biotech Management
| Name | Designation |
|---|---|
| Mr. Vivek Dhariwal | Chairman & Ind.Director |
| Mr. Hitesh Windlass | Managing Director |
| Mr. Manoj Kumar Windlass | Joint Managing Director |
| Mr. Pawan Kumar Sharma | Executive Director |
| Mr. Ashok Kumar Windlass | Whole Time Director |
| Mrs. Prachi Jain Windlass | Non Executive Director |
| Mr. Srinivasan Venkataraman | Independent Director |
| Mr. Gaurav Gulati | Independent Director |
Windlas Biotech Forecast
Price Estimates
Windlas Biotech Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-13 | Quarterly Results | |
| 2024-05-20 | Audited Results & Dividend | |
| 2024-02-08 | Quarterly Results | |
| 2023-11-08 | Quarterly Results | |
| 2023-08-08 | Quarterly Results |
Windlas Biotech FAQs
What is Share Price of Windlas Biotech ?
Windlas Biotech share price is ₹895 As on 18 September, 2024 | 02:23
What is the Market Cap of Windlas Biotech ?
The Market Cap of Windlas Biotech is ₹1871.2 Cr As on 18 September, 2024 | 02:23
What is the P/E ratio of Windlas Biotech ?
The P/E ratio of Windlas Biotech is 31.4 As on 18 September, 2024 | 02:23
What is the PB ratio of Windlas Biotech ?
The PB ratio of Windlas Biotech is 4.2 As on 18 September, 2024 | 02:23